Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-09-30Clinical Trial Update: Aranesp® Monthly Preference Study - 2 [Phase 4]
Phase 4 Aranesp monthly preference study in kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-01Clinical Trial Update: Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity [Phase 2]
A Phase 2 clinical trial evaluating time-dependent activity of erythropoietin therapy in patients with chronic kidney disease-related anemia…
-
CLINICAL_TRIALS trial_result · 2008-08-11Clinical Trial Update: Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients [Phase 2]
This update notes the completion of a Phase 2 trial evaluating intravenous n-3 fatty acids to reduce sudden cardiac death in hemodialysis pa…
-
CLINICAL_TRIALS trial_result · 2008-08-08Clinical Trial Update: Treatment for Subjects With Chronic Kidney Disease (CKD) Not Receiving Dialysis [Phase 3]
Phase 3 trial evaluating a treatment for chronic kidney disease in patients not on dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2008-08-08Clinical Trial Update: Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis [Phase 4]
Phase 4 clinical trial completed evaluating Aranesp (darbepoetin alfa) for treatment of anemia in African-American patients with chronic kid…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-08-01Clinical Trial Update: Efficacy and Safety of a 7.5% Icodextrin Peritoneal Dialysis Solution in Once-Daily Long Dwell Exchange [Phase 4]
Phase 4 trial evaluating the efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in once-daily long-dwell exchanges has co…
-
CLINICAL_TRIALS trial_result · 2008-07-25Clinical Trial Update: Endothelin Receptor Antagonism in Proteinuric Nephropathy [Phase 1]
A Phase 1 clinical trial from the University of Edinburgh evaluating endothelin receptor antagonism for proteinuric nephropathy has complete…
-
CLINICAL_TRIALS research · 2008-07-21Clinical Trial Update: Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD) [Phase 3]
A Phase 3 study of epoetin alfa in chronic kidney disease sponsored by Amgen has been terminated. The update notes the trial status but does…
-
CLINICAL_TRIALS trial_result · 2008-07-18Clinical Trial Update: Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes [Phase 4]
A Phase 4 completed trial comparing citrate-based versus acetate-based dialysate in bicarbonate haemodialysis to assess effects on haemodyna…
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) [Phase 4]
A Phase 4 trial (TANDEM) comparing Tarka (trandolapril/verapamil) with Lotrel (amlodipine/benazepril) in hypertensive, diabetic patients wit…
-
CLINICAL_TRIALS research · 2008-07-15Clinical Trial Update: Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure [Phase 4]
Phase 4 clinical trial update evaluating hydration with sodium bicarbonate to influence long-term outcomes in patients with chronic kidney d…
-
CLINICAL_TRIALS research · 2008-07-15Clinical Trial Update: An Observational Study of Pruritus Amongst Hemodialysis Patients
This document reports an observational study examining the occurrence of pruritus in patients undergoing hemodialysis for chronic kidney dis…
-
FDA label_change · 2008-06-18FDA Approved: ZEMPLAR — Supplemental Application (AbbVie Inc.)
FDA overview of AbbVie’s supplemental application for ZEMPLAR (paricalcitol) to update labeling.
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia [Phase 3]
This Phase 3 trial update evaluates the long-term safety and efficacy of a biosimilar epoetin (Biogeneric Epoetin) for anemia in patients wi…
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Circadian Rhythm of Erythropoietin And Melatonin in Renal Disease
The clinical trial studying circadian rhythms of erythropoietin and melatonin in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD) [Phase 3]
Phase 3 clinical trial evaluating Aranesp (darbepoetin alfa) in patients with anemia due to chronic kidney disease; the study status is comp…
-
CLINICAL_TRIALS trial_result · 2008-06-12Clinical Trial Update: Detection of Latent Tuberculosis in Hemodialysis Patients
This clinical trial update reports the completion and findings of a study evaluating methods to detect latent tuberculosis in patients under…
-
CLINICAL_TRIALS trial_result · 2008-06-06Clinical Trial Update: Relations Between Residual Renal Function and Oxidative and Carbonyl Stress in Peritoneal Dialysis Patients
This completed clinical trial studied the relationship between residual renal function and oxidative and carbonyl stress in patients undergo…
-
CLINICAL_TRIALS trial_result · 2008-06-04Clinical Trial Update: Trial of Aerobic Exercise in Patients Undergoing Outpatient Hemodialysis [NA]
Completed clinical trial evaluating the effects of aerobic exercise in patients with chronic kidney disease undergoing outpatient hemodialys…
-
CLINICAL_TRIALS trial_result · 2008-05-23Clinical Trial Update: Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
This completed clinical trial audited the effects of switching erythropoiesis-stimulating agents from intravenous to subcutaneous administra…
-
CLINICAL_TRIALS trial_result · 2008-05-21Clinical Trial Update: Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure? [Phase 2]
This update reports on a Phase 2 trial evaluating spironolactone for cardiovascular disease in patients with mild chronic kidney disease, fo…
-
CLINICAL_TRIALS trial_result · 2008-05-12Clinical Trial Update: Efficacy of Intravenous Iron Administration in Hemodialysis Patients [Phase 4]
Phase 4 clinical trial completed evaluating the efficacy of intravenous iron in patients with chronic kidney disease undergoing hemodialysis…
-
FDA approval · 2008-05-09FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for torsemide by Chartwell RX, LLC, updating an approved generic product (ANDA).
-
CLINICAL_TRIALS trial_result · 2008-05-09Clinical Trial Update: Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure [Phase 4]
Phase 4 trial update evaluating whether amlodipine affects mortality in patients with end-stage renal disease.
-
CLINICAL_TRIALS trial_result · 2008-05-07Clinical Trial Update: Safety Evaluation of Use Sodic Enoxaparin [Phase 3]
A Phase 3 safety evaluation of sodium enoxaparin in patients with kidney disease has completed.